Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Review
. 2023 Feb;28(1):101428.
doi: 10.1016/j.siny.2023.101428. Epub 2023 Mar 11.

Maternal and neonatal outcomes following SARS-CoV-2 infection

Affiliations
Review

Maternal and neonatal outcomes following SARS-CoV-2 infection

Lillian B Boettcher et al. Semin Fetal Neonatal Med. 2023 Feb.

Abstract

Infection with SARS-CoV-2 causing COVID-19 in pregnancy is known to confer risks to both the pregnant patient and fetus. A review of the current literature demonstrates that pregnant individuals with SARS-CoV-2 infection are at risk for higher composite morbidity, intensive care unit admission, ventilatory support, pre-eclampsia, preterm birth, and neonatal intensive care unit admissions compared to pregnant individuals without SARS-CoV-2. Worse obstetric morbidity and mortality generally correlate with the severity of COVID-19. Comorbidities such as diabetes increase the risk of severe COVID-19. An increased risk of stillbirth appears to be predominantly confined to pregnancies affected in the Delta variant time period. Further, vaccination against SARS-CoV-2 has been demonstrated to be safe and effective in pregnancy and while breastfeeding. Therefore, continued counseling encouraging vaccination remains imperative. The long-term maternal and neonatal consequences of pregnancies affected by SARS-CoV-2 remain unknown, and therefore continued research in this regard is warranted.

Keywords: COVID-19; Morbidity; Mortality; Outcomes; Pregnancy; SARS-CoV-2.

PubMed Disclaimer

Conflict of interest statement

Declaration of competing interest Dr. Metz reports personal fees from Pfizer for her role as a medical consultant for a SARS-CoV-2 vaccination in pregnancy study, grants from Pfizer for role as a site PI for SARS-CoV-2 vaccination in pregnancy study, grants from Pfizer for role as a site PI for RSV vaccination in pregnancy study, and grants from Gestvision for role as a site PI for a preeclampsia study outside the submitted work.

Figures

Fig. 1
Fig. 1
Percentage of pregnant people ages 18–49 years old who completed a primary vaccination series of the COVID-19 vaccine before and during pregnancy by week ending dates from January 2021 to February 2023. Adapted from data reported to the CDC via Vaccine Safety Data Link. Centers for Disease Control and Prevention. COVID Data Tracker. Atlanta GUDoHaHS, CDC; 2023, https://covid.cdc.gov/covid-data-tracker.
Fig. 2
Fig. 2
Pregnancy outcomes associated with COVID-19. Impact of the virus strain and benefits of vaccination are shown. RR – relative risk; PIH – pregnancy induced hypertension; PPH – postpartum hemorhage, a – adjusted; OR – odds ratio; CI- confidence interval; Image courtesy Satyan Lakshminrusimha.
Fig. 3
Fig. 3
Prevalence of the primary composite outcome of maternal death or serious morbidity from common obstetric complications, with 95% CIs, by month. Before pandemic is represented in light grey, and during pandemic is represented in dark grey. Dashed lines denote the overall prevalence of the primary outcome for March through December of each calendar year. Reprinted with permission from Metz et al. Association between giving birth during the early coronavirus disease 2019 (COVID-19) pandemic and serious maternal morbidity. Obstet Gynecol 2023.

References

    1. Son M., Gallagher K., Lo J.Y., et al. Coronavirus disease 2019 (COVID-19) pandemic and pregnancy outcomes in a US population. Obstet Gynecol. Oct 2021;138(4):542–551. doi: 10.1097/Aog.0000000000004547. - DOI - PMC - PubMed
    1. Seaton C.L., Cohen A., Henninger E.M., et al. Coronavirus disease 2019 (COVID-19) perinatal outcomes across the pandemic at an academic medical center in New York city. Obstet Gynecol. Oct 27 2022 doi: 10.1097/AOG.0000000000004978. - DOI - PubMed
    1. Seasely A.R., Blanchard C.T., Arora N., et al. Maternal and perinatal outcomes associated with the Omicron variant of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection. Obstet Gynecol. Aug 2022;140(2):262–265. doi: 10.1097/Aog.0000000000004849. - DOI - PMC - PubMed
    1. Centers for Disease Control and Prevention . Atlanta GUDoHaHS, CDC; 2023. COVID data tracker.https://covid.cdc.gov/covid-data-tracker February 15.
    1. Stock S.J., Carruthers J., Calvert C., et al. SARS-CoV-2 infection and COVID-19 vaccination rates in pregnant women in Scotland. Nat Med. Mar 2022;28(3):504. doi: 10.1038/s41591-021-01666-2. - DOI - PMC - PubMed

Publication types

Supplementary concepts